Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Damora Therapeutics, Inc. in Boston, MA, is seeking a Translational Medicine Scientist to drive translational research for our antibody-based oncology portfolio.
You will design and execute strategies and assays bridging discovery, clinical development, and biomarker science, collaborating across discovery, clinical development, bioinformatics, regulatory, and external partners. Reporting to the Head of Preclinical Development and Translational Medicine, you will lead assay development,
Damora Therapeutics, Inc. (Nasdaq: DMRA) is a Boston-based biotechnology company working to fundamentally redefine care for patients with blood disorders. Damora is advancing a new generation of subcutaneous biologics targeting mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis — chronic hematologic cancers with significant unmet need. The company’s lead program, DMR-001, is an investigational monoclonal antibody designed to selectively target mutant calreticulin, with additional programs (DMR-002 and DMR-003) advancing behind it.
This is a unique opportunity to join a science-driven company at a formative stage, where early clinical data will directly shape development strategy and drive long-term value. The right candidate will join a team with significant early- and late-stage development experience, with the goal of quickly moving through dose escalation/expansion into pivotal trials.
We are seeking an accomplished Translational Medicine Scientist to drive the strategic and scientific direction of translational research for our oncology portfolio, with a focus on antibody based therapeutics. This role is ideal for a scientist who thrives at the interface of discovery, clinical development, and biomarker science, and who brings deep expertise in oncology—preferably hematologic malignancies.
You will lead the design, development, and implementation of translational strategies and assays that enable data driven decision making in early and late stage clinical programs. This is a highly cross functional role requiring close collaboration with discovery research, clinical development, bioinformatics, regulatory, and external partners.
This role reports to the Head of Preclinical Development and Translational Medicine.